Phaarmasia Limited has announced that its board of directors will meet on Friday, May 29, 2026, via video conferencing. The primary agenda includes the consideration, review, and approval of the audited financial results for the quarter and year ended March 31, 2026.

Agenda Highlights

The board will deliberate on several key items during the meeting. The focus will be on the company's financial performance for the fourth quarter and the full fiscal year of 2026. Alongside the financial results, the directors will review the statutory auditor's report submitted for the same period.

Compliance and Appointments

In addition to financial results, the meeting will address regulatory compliance matters. The board will take note of the certificate under Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, for the quarter and year ended March 31, 2026.

The directors will also consider the appointment of an internal auditor for the financial year 2026-27. Furthermore, the board is set to approve the appointment of the secretarial auditor for the financial year 2025-26.

Meeting Details

The meeting is scheduled to commence at 4:30 P.M. The intimation was sent to the stock exchanges pursuant to Regulation 29 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Phaarmasia Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The Hyderabad-based pharmaceutical company filed the mandatory certificate for the quarter ended 31st March, 2026.

Regulatory Compliance Details

The compliance certificate was issued by Venture Capital and Corporate Investments Private Limited, serving as the company's Registrar and Share Transfer Agent. The certificate, dated 03rd April, 2026, addresses the requirements under Regulation 74(5) of SEBI regulations.

Dematerialization Compliance

The certificate confirms that Phaarmasia Limited has maintained compliance with dematerialization requirements during the quarter. According to the registrar's certification, securities received for dematerialization have been properly processed following established protocols.

Key compliance aspects covered include:

• Securities received for dematerialization have been mutilated and cancelled after due verification
• Depositories have been updated in company records as registered owners
• Processing completed within the mandatory 15-day period upon receipt of valid DRF and share certificates
• Details of securities furnished to relevant stock exchanges

Depository Partners

The certificate specifically mentions both major depositories in India:

• National Securities Depository Limited (NSDL)
• Central Depository Services (India) Limited (CDSL)

Both depositories have been updated in the company's records as registered owners, ensuring proper maintenance of investor records and seamless trading of dematerialized securities.

Corporate Communication

The filing was signed by Urvashi Bhatia, Company Secretary and Compliance Officer of Phaarmasia Limited (Membership No. ACS. 46877). The company has requested BSE Limited to acknowledge receipt of the compliance certificate and take it on record.

This quarterly filing demonstrates Phaarmasia Limited's commitment to maintaining regulatory compliance and ensuring proper handling of investor securities through established depository mechanisms.